CAI

Caris Life Sciences Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 0/10
  • Momentum↓ 0/10
Caris Life Sciences sales and earnings growth
CAI Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ 0.00%
  • FCF Y/Y↓ 0.00%
Caris Life Sciences gross and profit margin trends
CAI Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ 0.00%
Caris Life Sciences net debt vs free cash flow
CAI Risk
Great
  • Debt / Equity↓ 0.8
  • Debt / FCF↓ 0.0
  • Interest coverage↓ 0.0

Caris Life Sciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Diagnostics & Research stocks ↗